We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ISPE: Industrywide Quality Metrics Program Doable, but Costly
ISPE: Industrywide Quality Metrics Program Doable, but Costly
ISPE’s Quality Metrics Pilot Program shows that it’s feasible for drugmakers to collect and submit a standardized set of metrics data to the FDA, but not without considerable cost, a final report on phase one of the pilot concludes.